These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 28054132)

  • 1. Course of clinical high-risk states for psychosis beyond conversion.
    Michel C; Ruhrmann S; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):39-48. PubMed ID: 28054132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.
    Webb JR; Addington J; Perkins DO; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen RK; Seidman LJ; Tarbox SI; Tsuang MT; Walker EF; McGlashan TH; Woods SW
    Schizophr Bull; 2015 Sep; 41(5):1066-75. PubMed ID: 26272875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting psychosis in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
    Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPA guidance on the early detection of clinical high risk states of psychoses.
    Schultze-Lutter F; Michel C; Schmidt SJ; Schimmelmann BG; Maric NP; Salokangas RK; Riecher-Rössler A; van der Gaag M; Nordentoft M; Raballo A; Meneghelli A; Marshall M; Morrison A; Ruhrmann S; Klosterkötter J
    Eur Psychiatry; 2015 Mar; 30(3):405-16. PubMed ID: 25735810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study.
    Zhang T; Li H; Woodberry KA; Seidman LJ; Zheng L; Li H; Zhao S; Tang Y; Guo Q; Lu X; Zhuo K; Qian Z; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Schizophr Res; 2014 Feb; 152(2-3):391-9. PubMed ID: 24387999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups.
    Woods SW; Powers AR; Taylor JH; Davidson CA; Johannesen JK; Addington J; Perkins DO; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Seidman LJ; Tsuang MT; Walker EF; McGlashan TH
    Schizophr Bull; 2018 Feb; 44(2):254-263. PubMed ID: 29036402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.
    Schlosser DA; Jacobson S; Chen Q; Sugar CA; Niendam TA; Li G; Bearden CE; Cannon TD
    Schizophr Bull; 2012 Nov; 38(6):1225-33. PubMed ID: 21825282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
    Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting psychosis risk using a specific measure of cognitive control: a 12-month longitudinal study.
    Guo JY; Niendam TA; Auther AM; Carrión RE; Cornblatt BA; Ragland JD; Adelsheim S; Calkins R; Sale TG; Taylor SF; McFarlane WR; Carter CS
    Psychol Med; 2020 Oct; 50(13):2230-2239. PubMed ID: 31507256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
    Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
    Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.
    Salokangas RK; Ruhrmann S; von Reventlow HG; Heinimaa M; Svirskis T; From T; Luutonen S; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Klosterkötter J;
    Schizophr Res; 2012 Jul; 138(2-3):192-7. PubMed ID: 22464922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiety in youth at clinical high risk for psychosis.
    McAusland L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Early Interv Psychiatry; 2017 Dec; 11(6):480-487. PubMed ID: 26456932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affect recognition in people at clinical high risk of psychosis.
    Addington J; Piskulic D; Perkins D; Woods SW; Liu L; Penn DL
    Schizophr Res; 2012 Sep; 140(1-3):87-92. PubMed ID: 22763425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.